Patients with acute coronary syndromes (ACS) who take ticagrelor are known to be at higher risk for dyspnea than their counterparts who receive clopidogrel. New findings published online January 9, ...
New York, USA, Dec. 09, 2024 (GLOBE NEWSWIRE) -- Adenosine Antagonists Clinical Trial Pipeline Analysis: 10+ Key Companies Shaping the Future of Adenosine Antagonists Therapeutics | DelveInsight ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results